(Q34784781)

4 August 2017

1 reference

title

Malignancy in organ transplantation: heart (English)

1 reference

4 August 2017

main subject

organ transplantation

1 reference

Sharon A Hunt

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Transplantation Proceedings

4 August 2017

published in

1 reference

4 August 2017

volume

34

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

1874-1876

1 reference

The price of immunotherapy

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Posttransplant malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

ADVANCED DONOR-ORIGIN MELANOMA IN A RENAL TRANSPLANT RECIPIENT

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

The diagnosis and treatment of posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Treatment of organ transplant-related lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Cutaneous complications in immunosuppressed renal homograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Skin cancer in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Incidence of skin cancer after renal transplantation in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Skin cancer in heart transplant recipients: frequency and risk factor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

Cutaneous manifestations of immunosuppression in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903105-6

7 January 2021

10.1016/S0041-1345(02)03105-6

Identifiers

DOI

1 reference

4 August 2017

1 reference